• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Hematoma (1884); Incontinence (1928); Pain (1994); Urinary Tract Infection (2120); Injury (2348); Blood Loss (2597); Not Applicable (3189)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.Citation: am j obstet gynecol 2012;207:301.E1-7; doi: http://dx.Doi.Org/10.1016/j.Ajog.2012.08.016.(b)(4).
 
Event Description
It was reported via journal article "title: a multicenter, randomized, prospective, controlled study comparing sacrospinous fixation and transvaginal mesh in the treatment of posthysterectomy vaginal vault prolapse".Author(s): michael halaska, md, phd; katerina maxova, md; oldrich sottner, md; kamil svabik, md, phd; michal mlcoch, md; dusan kolarik, md; ivana mala, phd; ladislav krofta, md, phd; michael j.Halaska, md, phd.Citation: am j obstet gynecol 2012;207:301.E1-7; doi: http://dx.Doi.Org/10.1016/j.Ajog.2012.08.016.The objective of this multicenter, prospective, randomized, comparative study study was to compare recurrence and complication rates for sacrospinous fixation (ssf) and prolene mesh techniques for the primary treatment of posthysterectomy vaginal vault prolapse.A total of 168 patients with central posthysterectomy vaginal vault prolapse were randomized into 2 groups: ssf group (n=83) and mesh group (n=85).In ssf group, 2 nurolon stitches were anchored in the sacrospinous ligament and fixed to the vaginal cuff apex.In mesh group, prolift cannulas (gynecare, ethicon) was inserted with retrieval loops.Then, totatl prolift mesh was attached to the pubocervical fascia and vaginal wall using pds 2-0 sutures.At 3 months follow-up, complications included severe bleeding (n=6 ssf group; n=10 mesh group), hematoma (n=1 mesh group), bladder injury (n=1 ssf group; n=3 mesh group), abscess (n=1 mesh group), lower urinary tract (lut) infection (n=5 ssf group; n=1 mesh group), mesh exposure (n=12 mesh group), prolapse recurrence (n=13 ssf group; n=6 mesh group), de novo stress urinary incontinence (n=18 ssf group; n=21 mesh group), de novo overactive bladder (n=9 ssf group; n=7 mesh group), dyspareunia (n=2 ssf group; n=7 mesh group) and pelvic pain (n=3 ssf group; n=8 mesh group).At 12 months follow-up, complications included lower urinary tract (lut) infection (n=5 ssf group; n=3 mesh group), mesh exposure (n=16 mesh group), prolapse recurrence (n=28 ssf group; n=13 mesh group), de novo stress urinary incontinence (n=18 ssf group; n=27 mesh group), de novo overactive bladder (n=8 ssf group; n=8 mesh group), dyspareunia (n=2 ssf group; n=6 mesh group) and pelvic pain (n=3 ssf group; n=6 mesh group).In ssf group, out of 28 cases of prolapse recurrences, 3 patients underwent reoperations: anterior prolift (n=1), total prolift (n=1) and colpocleisis (n=1).While in mesh group, only one patient underwent reoperation by abdominal sacralcolpopexy.Of the vaginal mesh exposures, 10 were treated successfully by surgical resection of the protruded mesh and 6 cases resolved with local estrogen therapy.The high incidence of de novo sui in the ssf (25.4%) and mesh (35.1%) groups in our study is likely related to the correction of anterior prolapse because the successful correction of a cystocoele with or without meshes can unmask so-called potential sui.Mesh exposure occurrence was balanced against a lower prolapse recurrence rate in the patients undergoing mesh surgery compared with those undergoing ssf.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key8001992
MDR Text Key124962171
Report Number2210968-2018-76758
Device Sequence Number1
Product Code NEW
Combination Product (y/n)N
Reporter Country CodeEZ
PMA/PMN Number
N18331
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 10/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/24/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-